Dyadic International (DYAI) Current Assets (2017 - 2026)
Dyadic International's (DYAI) quarterly Current Assets came in at $7.7 million in Q1 2026, down 1.35% year-over-year from $7.8 million in Q1 2025, and down 22.2% quarter-over-quarter from $9.9 million in Q4 2025.
Analysis
Dyadic International (DYAI) Current Assets (2017 - 2026) Analysis & Trends
Dyadic International has disclosed Current Assets across 10 years of filings, most recently posting $7.7 million for Q1 2026.
- In Q1 2026, Current Assets fell 1.35% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (down 1.35% YoY), while the FY2025 annual figure was $9.9 million, up 0.7% from the prior year.
- Current Assets came in at $7.7 million for Q1 2026 at Dyadic International, down from $9.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $16.2 billion in Q1 2022 to a low of $7.4 million in Q2 2025.
- Average Current Assets over 5 years is $965.6 million, with a median of $10.7 million recorded in 2024.
- Year-over-year, Current Assets jumped 57922.59% in 2022 and slumped 99.92% in 2023.
- Over 5 years, Current Assets stood at $13.4 million in 2022, then plunged by 39.89% to $8.1 million in 2023, then rose by 21.82% to $9.8 million in 2024, then gained by 0.7% to $9.9 million in 2025, then dropped by 22.2% to $7.7 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $7.7 million in Q1 2026, $9.9 million in Q4 2025, and $11.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - | 7.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 9.90 Mn |
| Sep 30, 2025 | 11.55 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Mar 31, 2025 | 7.81 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 30, 2024 | 10.69 Mn |
| Jun 30, 2024 | 10.50 Mn |
| Mar 31, 2024 | 12.54 Mn |
| Dec 31, 2023 | 8.07 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Jun 30, 2023 | 11.07 Mn |
| Mar 31, 2023 | 12.81 Mn |
| Dec 31, 2022 | 13.42 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 16.93 Mn |
| Mar 31, 2022 | 16.24 Bn |
| Dec 31, 2021 | 21.01 Mn |
| Sep 30, 2021 | 23.57 Mn |
| Jun 30, 2021 | 26.16 Mn |